China Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

February 2024 | 46 pages | ID: C03EED05E774EN
MarketLine

Abstracts

China Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Summary

Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
• The Chinese biotechnology market recorded revenues of $63.4 billion in 2023, representing a compound annual growth rate (CAGR) of 10.4% between 2018 and 2023.
• The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $34.9 billion, equivalent to 55.1% of the market's overall value.
• The Chinese biotechnology market is experiencing growth due to innovation and potential therapeutic developments. China’s biotechnology market places a strong emphasis on research and development, and numerous businesses make large investments in this field. For instance, in August 2023, China introduced new attempts to attract foreign investors, promising to boost R&D in the biotech industry and "fast-track" cross-border data flows.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts

Reasons to Buy

• What was the size of the China biotechnology market by value in 2023?
• What will be the size of the China biotechnology market in 2028?
• What factors are affecting the strength of competition in the China biotechnology market?
• How has the market performed over the last five years?
• Who are the top competitors in China's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?

8 COMPANY PROFILES

8.1. BeiGene Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Sinovac Biotech Ltd.
8.4. Novo Nordisk A/S

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: China biotechnology industry value: $ million, 2018-23
Table 2: China biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: China biotechnology industry category segmentation: $ million, 2018-2023
Table 4: China biotechnology industry geography segmentation: $ million, 2023
Table 5: China biotechnology industry value forecast: $ million, 2023-28
Table 6: BeiGene Ltd: key facts
Table 7: BeiGene Ltd: Annual Financial Ratios
Table 8: BeiGene Ltd: Key Employees
Table 9: BeiGene Ltd: Key Employees Continued
Table 10: BeiGene Ltd: Key Employees Continued
Table 11: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 12: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 13: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 14: Sinovac Biotech Ltd.: key facts
Table 15: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 16: Sinovac Biotech Ltd.: Key Employees
Table 17: Novo Nordisk A/S: key facts
Table 18: Novo Nordisk A/S: Annual Financial Ratios
Table 19: Novo Nordisk A/S: Key Employees
Table 20: Novo Nordisk A/S: Key Employees Continued
Table 21: China size of population (million), 2019-23
Table 22: China gdp (constant 2005 prices, $ billion), 2019-23
Table 23: China gdp (current prices, $ billion), 2019-23
Table 24: China inflation, 2019-23
Table 25: China consumer price index (absolute), 2019-23
Table 26: China exchange rate, 2019-23

List Of Figures

LIST OF FIGURES

Figure 1: China biotechnology industry value: $ million, 2018-23
Figure 2: China biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: China biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in China, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2023